Drug Pricing Reform in 2021—Going Big or Going Bipartisan?-Reference-Cited by-同舟云学术

Drug Pricing Reform in 2021—Going Big or Going Bipartisan?

Published:2021-07-08 Issue:7 Volume:2 Page:e212372
ISSN:2689-0186
Container-title:JAMA Health Forum
language:en
Short-container-title:JAMA Health Forum

Author:

Dusetzina Stacie B.¹²,Mello Michelle M.³⁴

Affiliation:

1. Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee

2. Vanderbilt-Ingram Cancer Center, Nashville, Tennessee

3. Stanford Law School, Stanford, California

4. Stanford Heath Policy and the Department of Medicine, Stanford University School of Medicine, Stanford, California

Publisher

American Medical Association (AMA)

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

https://jamanetwork.com/journals/jama-health-forum/articlepdf/2781947/dusetzina_2021_jf_210031_1625678955.17136.pdf

Reference7 articles.

1. To address drug affordability, grab the low-hanging fruit.;Mello;JAMA,2021

2. Association of prescription drug price rebates in Medicare Part D with patient out-of-pocket and federal spending.;Dusetzina;JAMA Intern Med,2017

3. The case for restructuring the Medicare prescription drug benefit.;Frakt;Health Serv Res,2018

4. Congressional Budget Office. Budgetary effects of HR 3, the Elijah E. Cummings Lower Drug Costs Now Act. Published December 10, 2019. Accessed June 23, 2021. https://www.cbo.gov/system/files/2019-12/hr3_complete.pdf

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Growing Financial Burden From High-Cost Targeted Oral Anticancer Medicines Among Medicare Beneficiaries With Cancer;JCO Oncology Practice;2022-11

2. Consequences of forgoing prescription drug subsidies among low‐income Medicare beneficiaries with diabetes;Health Services Research;2022-04-27

3. Guideline‐concordant prescribing or medication adherence: A Medicare Part D predicament;Journal of the American Geriatrics Society;2022-04-05

4. Assessment of Hypothetical Out-of-Pocket Costs of Guideline-Recommended Medications for the Treatment of Older Adults With Multiple Chronic Conditions, 2009 and 2019;JAMA Internal Medicine;2022-02-01

5. We Should Treat Financial Toxicity With Curative, Rather Than Palliative, Intent;JCO Oncology Practice;2021-09-21